Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Some drugs for inflammation may cause psoriasis-like hair loss.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Reducing Tyrosinase prevents mature color pigment cells from forming in mouse hair.

Th22 cells are essential for Tβ15-induced hair growth in mice.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

New therapies are being developed that target integrin pathways to treat various diseases.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.